In This Section

The Victoria’s Secret Global Fund for Women’s Cancers 2022 Meritorious Awards, In Partnership with Pelotonia & AACR

Nomination StatusOpen
Nomination DeadlineJanuary 31, 2022
Description

The Victoria’s Secret Global Fund for Women’s Cancers 2022 Meritorious Awards, In Partnership with Pelotonia & AACR are intended to foster innovative research aimed at transforming outcomes for breast and gynecologic cancers, while also serving as an investment in the next generation of female cancer researchers worldwide. Importantly, this initiative will focus on the understanding, prevention, detection, diagnosis, and treatment of women’s cancers, with a goal of eliminating cancer health disparities and improving patient outcomes.

This program will include the recognition of five prominent and influential female cancer researchers who have made outstanding contributions to the fundamental understanding, prevention, and/or treatment of breast or any form of gynecologic cancer.

All award recipients will receive $100,000 and be formally recognized during the AACR Annual Meeting 2022 (AM2022) and Annual Pelotonia Signature Event Weekend. Award acceptances are contingent upon the recipients ability to be present at the AM2022 and discuss their selection (i.e., during press conferences and other promotional activities), unless otherwise unable to do so due to health and/or travel restrictions or other serious conflicts.

Upon their selection, each award recipient will be asked to nominate 3-5 outstanding early-stage investigators to be considered for scientific research grant funding.

For a period of three years post selection, award recipients will be expected to:

  • participate in biannual progress reviews of AACR-Pelotonia-Victoria’s Secret Global Fund for Women’s Cancers grants and networking events held in conjunction with AACR Annual Meetings and AACR-Pelotonia-Victoria’s Secret Global Fund for Women’s Cancers Grantees Symposia.
  • serve as unofficial mentors for all grantees awarded research funding through this program.
  • contribute to marketing activities such as public education campaigns dedicated to women’s health as well as breast and gynecologic cancers.
Eligibility Criteria

Awards will be presented to individual investigators who are affiliated with any institution involved in basic, prevention, translational, or clinical cancer research in the United States or abroad. Such institutions include those in the academic, industry, or government sectors.

Awards will be presented to female cancer researchers who have made significant contributions to the understanding, prevention, detection, diagnosis, and/or treatment of women’s cancers including, but not limited to breast, cervical, endometrial, ovarian, uterine, vaginal, and vulvar cancers.

Institutions and/or organizations are ineligible to receive these awards.

Contact Information

Please direct all inquiries pertaining to these award or any other AACR scientific achievement award or lectureship to Michael J. Powell, PhD, Deputy Director of Scientific Programs, at [email protected] or by phone at (215) 440-9373.

Nomination Criteria

Nominations may be submitted by an individual, whether an AACR member or nonmember, who is currently or has previously been affiliated with an institution involved in cancer research, cancer medicine, or cancer-related sciences.

Self-nominations are prohibited.

Nominators must maintain strict confidentiality of their nominations and all nominations must be submitted electronically to https://myaacr.aacr.org. Paper nominations will not be accepted.

Eligible nominations must include the following:

  • A nomination cover letter written in English (Max: 1,000 words), which describes the candidate’s outstanding contributions to the fundamental understanding, prevention, and/or treatment of breast or any form of gynecologic cancer. Additional information regarding the candidate’s leadership and mentorship qualities may also be included. Nominators are highly encouraged to submit candidate’s updated CV with nomination.
  • A brief citation (Max: 100 words) highlighting the major scientific contribution(s) as well as leadership and mentoring attributes of the candidate.
  • Completion of the questionnaire below intended to comprehensively capture the extent of the candidate’s scientific accomplishments, leadership qualities, and ability to mentor trainees and early-stage investigators.
    • Question One: How has the nominee contributed to advancing our understanding of women’s cancers (breast or gynecologic cancers) and how has their work transformed the lives of female cancer patients?
    • Question Two: How has the nominee demonstrated outstanding leadership both within their discipline and more broadly (e.g., outside of their immediate area of scientific expertise, outside of the lab/clinic, etc.) to accelerate progress in cancer research and patient care?
    • Question Three: How does the nominee steward a collaborative culture that promotes the pursuit of scientific advancement?
    • Question Four: Please describe how the nominee embodies a supportive and compassionate mentor to trainees and early-stage investigators.
    • Question Five (optional): Please provide any additional information in support of this nominee.

See the Program Guidelines and Nomination Instructions for complete details.

Selection Process

Eligible nominees will be considered by a Scientific Advisory Committee composed of an international group of cancer research experts appointed by the AACR in collaboration with Pelotonia and The Victoria’s Secret Global Fund for Women’s Cancers. Following the conclusion of all Scientific Advisory Committee deliberations, primary and alternate award recipient recommendations will be communicated to AACR, Pelotonia, and The Victoria’s Secret Global Fund for Women’s Cancers leadership bodies for formal ratification.

Selection of award recipients shall be made based on their scientific accomplishments without regard to race, nationality, geographic location, or religious or political views as well as demonstration of strong leadership and commitment to advancing the field and mentoring the next generation of cancer researchers.